Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BriaCell Therapeutics Announces Closing of $15 million Public Offering GlobeNewswire - Wed Jul 16, 3:05PM CDT

PHILADELPHIA and VANCOUVER, British Columbia, July 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Therapeutics Announces Pricing of $15 million Public Offering GlobeNewswire - Tue Jul 15, 2:05PM CDT

PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer GlobeNewswire - Tue Jul 15, 6:30AM CDT

PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer GlobeNewswire - Fri Jul 11, 6:30AM CDT

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient GlobeNewswire - Thu Jul 10, 6:30AM CDT

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study GlobeNewswire - Wed Jul 9, 6:30AM CDT

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer GlobeNewswire - Tue Jul 8, 6:30AM CDT

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven GlobeNewswire - Wed Jul 2, 6:30AM CDT

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer GlobeNewswire - Tue Jun 24, 6:30AM CDT

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 GlobeNewswire - Wed Jun 4, 6:30AM CDT

BCT.TO : 1.14 (+0.88%)
BCTXW : 0.0368 (-10.46%)
BCTXZ : 0.3300 (+10.04%)
BCTX : 0.8314 (+1.13%)

Barchart Exclusives

Robinhood Keeps Hitting New Highs. How Should You Play HOOD Stock Here? Barchart - Thu Jul 17, 6:50PM CDT
With Robinhood soaring to new highs in 2025, should investors chase the momentum or wait for a better entry point? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot